Michael O. Martinelli

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Melanocortin receptor agonists
- Patent number 7,314,879
- Issue date Jan 1, 2008
- Eli Lilly and Company
- Ryan Thomas Backer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin receptor agonists
- Patent number 7,291,619
- Issue date Nov 6, 2007
- Eli Lilly and Company
- Christopher Kelly Biggers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine- and piperidine-derivatives as melanocortin receptor ago...
- Patent number 7,186,715
- Issue date Mar 6, 2007
- Eli Lilly and Company
- Karin Briner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Melanocortin receptor agonists
- Patent number 7,169,777
- Issue date Jan 30, 2007
- Eli Lilly and Company
- Ryan Thomas Backer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperidines/piperazines as melanocortin receptor agonists
- Patent number 7,157,463
- Issue date Jan 2, 2007
- Eli Lilly and Company
- Ryan Thomas Backer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
spla2 inhibitors
- Patent number 6,713,505
- Issue date Mar 30, 2004
- Eli Lilly and Company
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cryptophycin compounds
- Patent number 6,680,311
- Issue date Jan 20, 2004
- Eli Lilly and Company
- Rima S Al-Awar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective iglur5 receptor antagonists
- Patent number 6,579,886
- Issue date Jun 17, 2003
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoprotein IIb/IIIa antagonists
- Patent number 6,448,269
- Issue date Sep 10, 2002
- Eli Lilly and Company
- Matthew J. Fisher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic sPLA2 inhibitors
- Patent number 6,384,041
- Issue date May 7, 2002
- Eli Lilly and Company
- Darrell Robert Hutchison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process to prepare pharmaceutical compounds
- Patent number 6,252,064
- Issue date Jun 26, 2001
- Eli and Company
- Michael John Martinelli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective sulphonation of the primary alcohol of a diol containing...
- Patent number 6,194,586
- Issue date Feb 27, 2001
- Eli Lilly and Company
- Michael J. Martinelli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoprotein IIB IIIA antagonists
- Patent number 6,020,362
- Issue date Feb 1, 2000
- Eli Lilly and Company
- Matthew J. Fisher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process and novel intermediates
- Patent number 6,020,512
- Issue date Feb 1, 2000
- Eli Lilly and Company
- Michael J. Martinelli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 4-substituted-1H-indole-3-glyoxamides
- Patent number 5,986,106
- Issue date Nov 16, 1999
- Eli Lilly and Company
- Vien Van Khau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazolecarboxamides
- Patent number 5,817,676
- Issue date Oct 6, 1998
- Eli Lilly and Company
- John T. Catlow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazolecarboxamides
- Patent number 5,798,367
- Issue date Aug 25, 1998
- Eli Lilly and Company
- John T. Catlow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz�CD!indoles
- Patent number 5,783,590
- Issue date Jul 21, 1998
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoprotein IIb/IIIa antagonists
- Patent number 5,731,324
- Issue date Mar 24, 1998
- Eli Lilly and Company
- Matthew J. Fisher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Excitatory amino acid receptor antagonists
- Patent number 5,675,008
- Issue date Oct 7, 1997
- Eli Lilly and Company
- Carl F. Bertsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzn [cd] indoles
- Patent number 5,665,744
- Issue date Sep 9, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
- Patent number 5,656,653
- Issue date Aug 12, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
- Patent number 5,654,324
- Issue date Aug 5, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indazolecarboxamides
- Patent number 5,654,320
- Issue date Aug 5, 1997
- Eli Lilly and Company
- John T. Catlow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing isoquinoline compounds
- Patent number 5,648,492
- Issue date Jul 15, 1997
- Eli Lilly and Company
- M. Brian Arnold
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles
- Patent number 5,648,356
- Issue date Jul 15, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[CD]indoles
- Patent number 5,643,910
- Issue date Jul 1, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles
- Patent number 5,643,934
- Issue date Jul 1, 1997
- Eli Lilly and Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
- Patent number 5,641,794
- Issue date Jun 24, 1997
- Eli Lilly Company
- Richard N. Booher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process of preparing isoquinoline compounds
- Patent number 5,637,712
- Issue date Jun 10, 1997
- Eli Lilly and Company
- Carl F. Bertsch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS
- Publication number 20090062358
- Publication date Mar 5, 2009
- Ivan Collado Cano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin receptor agonists
- Publication number 20050075344
- Publication date Apr 7, 2005
- Ryan Thomas Backer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin receptor agonists
- Publication number 20040116699
- Publication date Jun 17, 2004
- Ryan Thomas Backer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Peroxisome proliferator activated receptor alpha agonists
- Publication number 20040102500
- Publication date May 27, 2004
- Ivan Collado Cano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin receptor agonists
- Publication number 20040092507
- Publication date May 13, 2004
- Christopher Kelly Biggers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine- and piperidine-derivatives as melanocortin receptor ago...
- Publication number 20040082590
- Publication date Apr 29, 2004
- Karin Briner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Excitatory amino acid receptor antagonists
- Publication number 20040082606
- Publication date Apr 29, 2004
- Vien Van Khau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for producing amino-substituted chromanes
- Publication number 20040014804
- Publication date Jan 22, 2004
- Luc Antoine
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for resolving chiral (2s) and (2r) chromanes
- Publication number 20040014994
- Publication date Jan 22, 2004
- Luc Antoine
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel spla2 inhibitors
- Publication number 20030236232
- Publication date Dec 25, 2003
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glycoprotein llb/llla antagonists
- Publication number 20030130342
- Publication date Jul 10, 2003
- Matthew J. Fisher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective iglur5 receptor antagonists
- Publication number 20030055081
- Publication date Mar 20, 2003
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY

Michael O. Martinelli

Person

Patents Grantslast 30 patents

Melanocortin receptor agonists

Melanocortin receptor agonists

Piperazine- and piperidine-derivatives as melanocortin receptor ago...

Melanocortin receptor agonists

Substituted piperidines/piperazines as melanocortin receptor agonists

spla2 inhibitors

Cryptophycin compounds

Selective iglur5 receptor antagonists

Glycoprotein IIb/IIIa antagonists

Bicyclic sPLA2 inhibitors

Process to prepare pharmaceutical compounds

Selective sulphonation of the primary alcohol of a diol containing...

Glycoprotein IIB IIIA antagonists

Process and novel intermediates

Process for preparing 4-substituted-1H-indole-3-glyoxamides

Indazolecarboxamides

Indazolecarboxamides

6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz�CD!indoles

Glycoprotein IIb/IIIa antagonists

Excitatory amino acid receptor antagonists

6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzn [cd] indoles

6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles

6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles

Indazolecarboxamides

Process for preparing isoquinoline compounds

6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles

6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[CD]indoles

6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles

6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles

Process of preparing isoquinoline compounds

Patents Applicationslast 30 patents

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS

Melanocortin receptor agonists

Melanocortin receptor agonists

Peroxisome proliferator activated receptor alpha agonists

Melanocortin receptor agonists

Piperazine- and piperidine-derivatives as melanocortin receptor ago...

Excitatory amino acid receptor antagonists

Methods for producing amino-substituted chromanes

Method for resolving chiral (2s) and (2r) chromanes

Novel spla2 inhibitors

Glycoprotein llb/llla antagonists

Selective iglur5 receptor antagonists